Oncology Institute Inc. (TOI)
NASDAQ: TOI
· Real-Time Price · USD
3.60
0.12 (3.45%)
At close: Sep 24, 2025, 3:59 PM
3.60
0.00%
After-hours: Sep 24, 2025, 07:54 PM EDT
3.45% (1D)
| Bid | 3.43 |
| Market Cap | 336.58M |
| Revenue (ttm) | 424.38M |
| Net Income (ttm) | -65.89M |
| EPS (ttm) | -0.67 |
| PE Ratio (ttm) | -5.37 |
| Forward PE | -16.29 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.66 |
| Volume | 1,131,192 |
| Avg. Volume (20D) | 1,989,784 |
| Open | 3.52 |
| Previous Close | 3.48 |
| Day's Range | 3.38 - 3.63 |
| 52-Week Range | 0.13 - 4.50 |
| Beta | 0.13 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for TOI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsOncology Institute Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-10.49%
The Oncology Institute shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
+28.27%
The Oncology Institute shares are trading higher after the company reported a year-over-year increase in Q1 financial results.
1 month ago · seekingalpha.com
The Oncology Institute, Inc. (TOI) Q2 2025 Earnings Call TranscriptThe Oncology Institute, Inc. (NASDAQ:TOI ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Daniel Virnich - CEO & Executive Director Mark Hueppelsheuser - Corporate Pa...